Authors:
PITT J
GOLDFARB J
SCHLUCHTER M
KOVACS A
COOPER E
HODES D
MCINTOSH K
PEAVY H
SHEARER W
Citation: J. Pitt et al., HIV VERTICAL TRANSMISSION RATE DETERMINATIONS ARE SUBJECT TO DIFFERING DEFINITIONS AND THEREFORE DIFFERENT RATES, Journal of clinical epidemiology, 51(2), 1998, pp. 159-164
Authors:
RUIZHUIDOBRO E
ABRAMSON S
ROSENBLATT HM
HANSON C
PAUL M
SHEARER W
Citation: E. Ruizhuidobro et al., PERSISTENT IMMUNOSUPPRESSION AFTER CHEMOTHERAPY - DRUG EFFECT VS NATURAL-HISTORY, Journal of allergy and clinical immunology, 101(1), 1998, pp. 303-303
Citation: J. Monagle et al., ORAL MEDICATION FOR POSTCESAREAN ANALGESIA, Australian and New Zealand Journal of Obstetrics and Gynaecology, 38(2), 1998, pp. 169-171
Citation: W. Shearer et al., A MODEL OF COMMUNITY-BASED, PREADMISSION MANAGEMENT FOR ELECTIVE SURGICAL PATIENTS, Canadian journal of anaesthesia, 44(12), 1997, pp. 1311-1314
Authors:
TUOMALA RE
KALISH LA
ZORILLA C
FOX H
SHEARER W
LANDAY A
VERMUND SH
LANDESMAN S
BURNS D
Citation: Re. Tuomala et al., CHANGES IN TOTAL, CD4(-INFECTED WOMEN(), AND CD8(+) LYMPHOCYTES DURING PREGNANCY AND 1 YEAR POSTPARTUM IN HUMAN IMMUNODEFICIENCY VIRUS), Obstetrics and gynecology, 89(6), 1997, pp. 967-974
Authors:
KATTAN M
BECK G
BOYETT J
KAPLAN S
LIPSHULTZ S
MELLINS R
MOODIE D
PLATZKER A
PEAVY H
SCHLUCHTER M
SHEARER W
WEINSTEIN C
WU M
Citation: M. Kattan et al., PEDIATRIC PULMONARY AND CARDIOVASCULAR COMPLICATIONS OF VERTICALLY TRANSMITTED HUMAN-IMMUNODEFICIENCY-VIRUS (P2C2 HIV) INFECTION STUDY - DESIGN AND METHODS, Journal of clinical epidemiology, 49(11), 1996, pp. 1285-1294
Citation: A. Kuruvilla et al., ACTIVATION OF MULTIPLE SIGNAL-TRANSDUCTION INTERMEDIATES BY PLATELET-ACTIVATING-FACTOR (PAF) IN A HUMAN B-CELL LINE, The FASEB journal, 8(4), 1994, pp. 10000469-10000469
Citation: J. Mcclure et al., P53 EXHIBITS A DEPHOSPHORYLATION DEPENDENT CONFORMATIONAL CHANGE DURING LYMPHOCYTE-ACTIVATION, Journal of cellular biochemistry, 1994, pp. 102-102
Authors:
CONNOR EM
SPERLING RS
GELBER R
KISELEV P
SCOTT G
OSULLIVAN MJ
VANDYKE R
BEY M
SHEARER W
JACOBSON RL
JIMENEZ E
ONEILL E
BAZIN B
DELFRAISSY JF
CULNANE M
COOMBS R
ELKINS M
MOYE J
STRATTON P
BALSLEY J
Citation: Em. Connor et al., REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT, The New England journal of medicine, 331(18), 1994, pp. 1173-1180
Citation: A. Kuruvilla et al., TYROSINE PHOSPHORYLATION OF PHOSPHOLIPASE-C IS ESSENTIAL FOR ITS ACTIVATION BY PLATELET-ACTIVATING-FACTOR IN A HUMAN B-CELL LINE, The Journal of immunology, 150(8), 1993, pp. 168-168
Citation: J. Monagle et al., KETOROLAC VERSUS FENTANYL FOR GYNECOLOGICAL DAY-CASE SURGERY, Australian and New Zealand Journal of Obstetrics and Gynaecology, 33(4), 1993, pp. 430-432